TLIS (Talis Biomedical) Days Payable: 0.00 (As of Jun. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TLIS Talis Biomedical Corp TLIS
28 GF Score
Price $2.84
View Full Analysis

What is Talis Biomedical Days Payable?

Talis Biomedical TLIS 28 Days Payable is 0.00 as of Jun. 2024. GuruFocus rates TLIS with a GF Score™ of 28/100.

Talis Biomedical's average Accounts Payable for the three months ended in Jun. 2024 was $3.70 Mil. Talis Biomedical's Cost of Goods Sold for the three months ended in Jun. 2024 was $0.00 Mil.

The historical rank and industry rank for Talis Biomedical's Days Payable or its related term are showing as below:

TLIS's Days Payable is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 67.87
* Ranked among companies with meaningful Days Payable only.

Talis Biomedical's Days Payable declined from Jun. 2023 (41,466.61) to Jun. 2024 (0.00). It may suggest that Talis Biomedical accelerated paying its suppliers.

Talis Biomedical Days Payable Historical Data

* Premium members only.

The historical data trend for Talis Biomedical's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Talis Biomedical Days Payable Chart

Talis Biomedical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial 0.00 0.00 0.00 193.35 22,732.38

Talis Biomedical Quarterly Data
Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41,466.61 39,450.42 23,017.81 37,701.46 0.00

TLIS vs BJDX, BBLG, VTAK: Days Payable Comparison

For the Medical Devices subindustry, Talis Biomedical's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Talis Biomedical Days Payable vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Talis Biomedical's Days Payable distribution charts can be found below:

* The bar in red indicates where Talis Biomedical's Days Payable falls into.


TLIS
28GF Score
Talis Biomedical Corp TLIS
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Talis Biomedical Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Talis Biomedical's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (3.768 + 1.339) / 2 ) / 0.041*365
=2.5535 / 0.041*365
=22,732.38

Talis Biomedical's Days Payable for the quarter that ended in Jun. 2024 is calculated as:

Days Payable (Q: Jun. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Mar. 2024 ) + Accounts Payable (Q: Jun. 2024 )) / count ) / Cost of Goods Sold (Q: Jun. 2024 )*Days in Period
=( (3.619 + 3.79) / 2 ) / 0*365 / 4
=3.7045 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Talis Biomedical (TLIS) has a Days Payable of 0.00 as of Jun. 2024. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Talis Biomedical and its competitors.
Is Talis Biomedical's Days Payable too high?
Talis Biomedical's current Days Payable is 0.00. Overall, Talis Biomedical has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Talis Biomedical's Days Payable compare to BJDX and BBLG?
Talis Biomedical's Days Payable of 0.00 can be compared against companies in the Medical Devices & Instruments industry. The industry median Days Payable is 67.87. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Talis Biomedical and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Talis Biomedical's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Talis Biomedical stock overvalued right now?
Talis Biomedical (TLIS) has a current Days Payable of 0.00. The current Days Payable is 0.00. Talis Biomedical's overall GF Score™ is 28/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Talis Biomedical (TLIS), the current Days Payable is 0.00 as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Talis Biomedical Business Description

Address 1375 West Fulton Market, Suite 700, Chicago, IL, USA, 60607
Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care. Its Talis One System is a molecular diagnostic platform developed to enable point-of-care testing for infectious diseases such as COVID-19.
28GF Score

Get the complete analysis for TLIS

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.84
Price